Theriva Biologics
TOVX
TOVX
21 hedge funds and large institutions have $272K invested in Theriva Biologics in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.71% less ownership
Funds ownership: 4.55% → 3.84% (-0.71%)
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$70.8K | |
| 2 | +$59.1K | |
| 3 | +$54.4K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$49.8K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$12.7K |
Top Sellers
| 1 | -$15K | |
| 2 | -$14.9K | |
| 3 | -$11.1K | |
| 4 |
Two Sigma Investments
New York
|
-$5.77K |
| 5 |
HF
HRT Financial
New York
|
-$4K |
